A carregar...
Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges
Triple negative breast cancer (TNBC) is an aggressive breast cancer with historically poor outcomes, primarily due to the lack of effective targeted therapies. The tumor molecular heterogeneity of TNBC has been well recognized, yet molecular subtype driven therapy remains lacking. While neoadjuvant...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7352772/ https://ncbi.nlm.nih.gov/pubmed/32486021 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12061404 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|